Please review the guidelines and submit an abstract to Diabetes Technology Meeting 2023 by July 3, 2023.
The Lipohypertrophy and Insulin webinar was held on April 26, 2023 from 9 AM to 10:35 AM Pacific Time.
Join the DTS mailing list
and receive updates
delivered to your inbox.
HEALIO: Use of CGM metrics more common in diabetes care, but still limited
HEALIO: VIDEO: New metric from CGM data provides single score for glucose assessment
MEDSCAPE: What Is the Glycemic Risk Index and Why Do We Need It?
UPI: Pacemakers, insulin pumps can be hacked, experts say
HEALIO: Glycemia Risk Index provides new tool for assessing glycemic control with CGM data
HEALIO: Stakeholders challenged to take action at first Green Diabetes Summit
MEDSCAPE: Continuous Ketone Monitoring Has Potential to Cut DKA in Diabetes
DIATRIBE: Glycemia Risk Index – An Emerging Measurement to Complement Your TIR
HEALIO: Connectivity, digital tools becoming the ‘sixth vital sign’ in health care
MEDSCAPE: Wearable Continuous Ketone Monitoring Appears Feasible
HEALIO: Continuous ketone monitoring may provide early identification of DKA
HP ENTERPRISE.NXT: How the edge is reshaping healthcare
MEDSCAPE: Protecting Patients With Diabetes From Impact of COVID-19
ENDOCRINOLOGY ADVISOR: Benefits of Continuous Glucose Monitoring Systems in the Hospital Setting
HEALIO: Telehealth shift during COVID-19 pandemic shows capacity to deliver safe, convenient care
ENDOCRINE NEWS: New App Helps Improve Diabetes Care in Patients with COVID-19
ENDOCRINE NEWS: Pandemic Parallels: Glycemic Control in COVID-19 Patients
MEDSCAPE: Largest Study to Date Links Glucose Control to COVID-19 Outcomes
NEWSDAY: Coronavirus poses special risks for diabetics
HEALIO: Uncontrolled hyperglycemia, diabetes drive longer hospital stay, mortality in COVID-19
ELSEVIER: Diabetes Digital Health (Edited by David Klonoff et al.)
HEALIO: Postoperative infections less frequent with insulin pump therapy for adults with diabetes
THE DIPLOMAT: Cost of Diabetes Reaches $850 Billion a Year Globally